Tinkov Steliyan, Bekeredjian Raffi, Winter Gerhard, Coester Conrad
Department of Pharmaceutical Technology and Biopharmaceutics, Ludwig-Maximilians University-Munich, Butenandtstr. 5-13, D-81377 Munich, Germany.
J Pharm Sci. 2009 Jun;98(6):1935-61. doi: 10.1002/jps.21571.
Originally developed as contrast agents for ultrasound imaging and diagnostics, in the past years, microbubbles have made their way back from the patients' bedside to the researcher's laboratory. Microbubbles are currently believed to have great potential as carriers for drugs, small molecules, nucleic acids, and proteins. This review provides insight into this intriguing new frontier from the perspective of the pharmaceutical scientist. First, basic aspects on the application of ultrasound-targeted microbubble destruction for drug delivery will be presented. Next, we will review the recently applied approaches for manufacturing and drug-loading microbubbles. Important quality issues and characterization techniques for advanced microbubble formulation will be discussed. Finally, we will provide an assessment of the prospects for microbubbles in drug and gene therapy, illustrating the problems and requirements for their future development.
微泡最初是作为超声成像和诊断的造影剂而开发的,在过去几年中,它们又从患者床边回到了研究人员的实验室。目前人们认为微泡作为药物、小分子、核酸和蛋白质的载体具有巨大潜力。本综述从药物科学家的角度深入探讨了这一引人入胜的新领域。首先,将介绍超声靶向微泡破坏用于药物递送的基本方面。接下来,我们将回顾最近应用于制造和装载药物的微泡的方法。将讨论先进微泡制剂的重要质量问题和表征技术。最后,我们将对微泡在药物和基因治疗中的前景进行评估,阐明其未来发展的问题和要求。